author-photo

Michaela Marggraf

Dresden University of Technology

2

Papers

41

Citations

Citation Trend

Filter By

Papers (2) Sort By

Journal Conference Others

Event-Driven Immunoprofiling Predicts Return of Disease Activity in Alemtuzumab-Treated Multiple Sclerosis

2020 Frontiers in Immunology
Show All
- Source
- Cite
- Save
Citations (12)
New insights into the pharmacokinetics and pharmacodynamics of natalizumab treatment for patients with multiple sclerosis, obtained from clinical and in vitro studies

2016 Journal of Neuroinflammation
Show All
- Source
- Cite
- Save
Citations (29)